Guk Haeng Lee

ORCID: 0000-0003-4766-9556
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Thyroid and Parathyroid Surgery
  • Parathyroid Disorders and Treatments
  • Thyroid Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Oral Health Pathology and Treatment
  • Cleft Lip and Palate Research
  • Genetic Syndromes and Imprinting
  • Medical Imaging and Pathology Studies
  • Head and Neck Anomalies
  • Pituitary Gland Disorders and Treatments
  • Soft tissue tumor case studies
  • Voice and Speech Disorders
  • Salivary Gland Tumors Diagnosis and Treatment

Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to develop clinical practice guidelines for the surgical treatment laryngeal cancer. This conducted systematic search EMBASE, MEDLINE, Cochrane Library, KoreaMed databases identify relevant articles, using terms selected according key questions. Evidence-based recommendations were then created on basis these articles. An external expert review Delphi questionnaire applied reach consensus regarding recommendations. The...

10.21053/ceo.2016.01389 article EN cc-by-nc Clinical and Experimental Otorhinolaryngology 2017-01-02

Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to provide guidance on the implementation surgical treatment oral cancer. MEDLINE databases were searched for articles subjects related "surgical management cancer" published in English. Results restricted systematic reviews, randomized control trials/controlled clinical trials, observational studies. The quality evidence was rated with use RoBANS (Risk Bias Assessment Tool Nonrandomized Studies) AMSTAR (A Measurement...

10.21053/ceo.2018.01816 article EN cc-by-nc Clinical and Experimental Otorhinolaryngology 2019-02-01

Thyroid-stimulating hormone (TSH) suppression is recommended for patients who undergo thyroidectomy differentiated thyroid cancer (DTC). However, the impact of TSH on clinical outcomes in low-risk DTC remains uncertain. Therefore, we investigated effects postoperative levels recurrence with after lobectomy.Patients (n=1,528) underwent lobectomy papillary carcinoma between 2000 and 2012 were included this study. According to mean dominant values during entire follow-up period or 5 years,...

10.3803/enm.2019.34.2.150 article EN cc-by-nc Endocrinology and Metabolism 2019-01-01

Summary Objective There is debate whether hemithyroidectomy sufficient for patients with papillary thyroid cancer ( PTC ) sized 1‐4 cm. Therefore, we investigated affects recurrence rate compared thyroidectomy in Design Retrospective observational study. Patients We included 147 cm who underwent between 2004 and 2008. They were matched 298 thyroidectomy, comparing age, sex, tumour size, multiplicity, extrathyroidal extension status lymph node LN metastasis status. Measurements...

10.1111/cen.13336 article EN Clinical Endocrinology 2017-03-24

Background The intraoperative parathyroid hormone (IOPTH) assay is widely used in patients with primary hyperparathyroidism (PHPT). We investigated the usefulness of IOPTH Korean PHPT. Methods retrospectively reviewed data 33 PHPT who underwent parathyroidectomy. Neck ultrasonography (US) and 99mTc-sestamibi scintigraphy (MIBI scan) were performed preoperatively assays conducted. Results sensitivity neck US MIBI scans 91% 94%, respectively. A 50% decrease (PTH) levels 10 minutes after...

10.3803/enm.2014.29.4.464 article EN cc-by-nc Endocrinology and Metabolism 2014-01-01

서 론원발성 부갑상선암은 1904년 de Quevain 1) 에 의해 최초 발표된 이후 전세계적으로 700여 증례만 보고 2) 될 정도로 드 문 질환으로 초기에는 특이한 증상이 없으나 대부분 신결석, 대사성 골 병변 등을 수반한 합병증에 발견된다. 3)대사성 병변, 즉 갈색종은 부갑상선 기능항진증에 의한 것으로 일차성의 경우 선종에 발생하 고 부갑상선암에 경우는 5% 미만을 차지한다

10.3342/kjorl-hns.2014.57.8.562 article KO Korean Journal of Otorhinolaryngology - Head and Neck Surgery 2014-01-01
Coming Soon ...